Clinical Trial: Sequential Treatment Approaches for Treatment-Resistant Schizophrenia

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918222) titled 'Sequential Treatment Approaches for Treatment-Resistant Schizophrenia' on July 14.

Brief Summary: The goal of this study is to optimize treatment strategies for Chinese patients with treatment-resistant schizophrenia (TRS). It will compare two types of treatment:

1. Drug therapy with clozapine alone or in combination with other medications.

2. Neuromodulation therapy, modified electroconvulsive therapy (MECT) or magnetic seizure therapy (MST).

The study aims to determine which approach provides better symptom improvement, fewer cognitive side effects, and greater overall safety. The results may provide important clinical evidence ...